The effect of six years lasting primary non pharmacological prevention of coronary heart disease on hypercholesterolemia in occupationally working men
Kocemba, J.; Kawecka-Jaszcz, K.; Magdoń, M.
Przeglad Lekarski 38(12): 857-860
1981
ISSN/ISBN: 0033-2240 PMID: 7345479 Document Number: 176496
Document emailed within 1 workday
Related Documents
Zhang, H.; Jiang, Y.; Nguyen, H.D.; Poo, D.Chiang.Choon.; Wang, W. 2017: The effect of a smartphone-based coronary heart disease prevention (SBCHDP) programme on awareness and knowledge of CHD, stress, and cardiac-related lifestyle behaviours among the working population in Singapore: a pilot randomised controlled trial Health and Quality of Life Outcomes 15(1): 49Samuelsson, O.G.; Wilhelmsen, L.W.; Pennert, K.M.; Wedel, H.; Berglund, G.L. 1990: The J-shaped relationship between coronary heart disease and achieved blood pressure level in treated hypertension: further analyses of 12 years of follow-up of treated hypertensives in the Primary Prevention Trial in Gothenburg, Sweden Journal of Hypertension 8(6): 547-555
Gryglik, J. 1979: Pharmacological inhibition of platelet aggregation in primary and secondary prevention of ischemic heart disease Polski Tygodnik Lekarski 34(13): 509-511
Menotti, A. 1977: Prevention of coronary heart disease. A problem re-examined after 6 years Giornale Italiano di Cardiologia 7(8): 751-755
Meinertz, T.; Heitzer, T. 2002: Primary and secondary prevention of coronary heart disease: smoking Zeitschrift für Kardiologie 91 Suppl. 2: 3-11
Kannel, W.B. 1990: Implications of the primary prevention trials against coronary heart disease Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 8(7): S245-S250
Gliksman, M.D.; Dwyer, T.; Boulton, T.J. 1987: Should the primary prevention of coronary heart disease commence in childhood? Medical Journal of Australia 146(7): 360-362
Wicklmayr, M.; Rett, K.; Standl, E. 1994: How can primary prevention of coronary heart disease be improved in general practice? Medizinische Klinik 89(4): 184-6 229
Wilhelmsen, L. 1977: Primary and secondary risk factors for coronary heart disease: their role in prevention Medical Journal of Malaysia 31(4): 296-301
Carneiro, Aónio.Vaz.; Costa, Jão.; Borges, M. 2004: Statins for primary and secondary prevention of coronary heart disease. A scientific review Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 23(1): 95-122
Stamler, J. 1973: Heart disease prevention in industry. Primary prevention in mass community efforts to control the major coronary risk factors: the challenges and possibilities--critical issues and outlook for the future Journal of Occupational Medicine.: Official Publication of the Industrial Medical Association 15(1): 54-59
Grundy, S.M. 1992: Primary prevention of coronary heart disease with drug therapy. Safety and total mortality issues Archives of Internal Medicine 152(7): 1369-1371
Cucu, F.; Purice, S.; Schioiu-Costache, L.; Damşa, T.; Suciu, A.; Cherciu, A.; Steinbach, M. 1991: Seasonal variations of serum cholesterol detected in the Bucharest Multifactorial Prevention Trial of Coronary Heart Disease. Ten years follow-up (1971-1982) Romanian Journal of Internal Medicine 29(1-2): 15-21
Martens, L.L.; Guibert, R. 1994: Cost-effectiveness analysis of lipid-modifying therapy in Canada: comparison of HMG-CoA reductase inhibitors in the primary prevention of coronary heart disease Clinical Therapeutics 16(6): 1052-62; discussion 1036
Chotkowska, E.; Rywik, S.; Szostak, W.B.; Charzewska, J.; Sznajd, J.; Wasowicz, B.; Magdoń, M.; Nowacki, G. 1979: The prevalence of hypercholesterolemia in the male population covered by Polish trial on prevention of ischaemic heart disease Przeglad Lekarski 36(10): 737-741
Consentino, F. 1987: Coronary heart disease in working women Rivista Europea Per le Scienze Mediche e Farmacologiche 9(4): 369-390
Irgashev, S.B.; Iuldashev, N.M. 1987: Effect of hypercholesterolemia on the macroergic content and size of necrotic area in the heart muscle in acute coronary occlusion in rabbits Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 3: 62-64
Kittel, F.; Kornitzer, M.; De Backer, G.; Dramaix, M. 1982: The Belgian Heart Disease Prevention Project: type A behavior pattern and the prevalence of coronary heart disease Activitas Nervosa Superior Suppl. 3(Pt 1): 78-83
Kozák, P. 1982: Increasing the sensitivity of systolic time intervals in coronary heart disease patients by means of stimulated tachycardia and pharmacological heart loads (isoproterenol, nitroglycerine, propranolol) Acta Universitatis Carolinae. Medica 28(5-6): 369-382
Sen, S.; Sen, K.; Das, D. 2020: Differential effect of catechin hydrate and caffeine and it's metabolite on prevention of methemoglobinemia caused by nitrate and nitrite containing drugs used for the treatment of coronary heart disease Journal of the Association of Physicians of India 68(1): 105